BFR Therapy for Post-Knee Arthroscopy Recovery
(ACL BFR Trial)
Trial Summary
What is the purpose of this trial?
This trial investigates if using Blood Flow Restriction (BFR) therapy can help patients recover faster and stronger after knee surgery. BFR uses a special cuff to limit blood flow during exercise, making muscles grow and strengthen with less effort. The goal is to see if this method improves recovery better than standard rehabilitation alone.
Do I have to stop taking my current medications for the trial?
The trial does not specify if you need to stop taking your current medications. However, if you are taking blood thinners, you may not be eligible to participate.
What data supports the effectiveness of the treatment BFR Therapy for post-knee arthroscopy recovery?
Is Blood Flow Restriction Therapy safe for humans?
Blood Flow Restriction Therapy (BFR) has been studied for various conditions and is generally considered safe when applied correctly, although there is no standardized application among practitioners. It involves using a cuff to restrict blood flow during exercise, which can help improve muscle strength and reduce pain.15678
How does BFR therapy differ from other treatments for post-knee arthroscopy recovery?
BFR therapy is unique because it uses a tourniquet to partially restrict blood flow while exercising, which allows for muscle strengthening with low resistance. This method helps improve muscle strength and size without the need for heavy weights, making it particularly beneficial for recovery after knee surgery.13458
Research Team
James Genuario, MD
Principal Investigator
University of Colorado, Denver
Eligibility Criteria
This trial is for patients who've had knee arthroscopy and are rehabilitating from ACL reconstruction. They must be able to use a smartphone with the SAGA BFR app. It's not for those with MCL repairs, clotting disorders, recent severe cardiovascular or brain events, untreated blood pressure issues, pregnancy/postpartum within 6 months, poor English understanding, recent major injuries or surgeries on both knees close together.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo post-operative physical therapy with or without Blood Flow Restriction (BFR) therapy following knee arthroscopy
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of knee extensor strength and other functional measures
Treatment Details
Interventions
- BFR Therapy (Other)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Colorado, Denver
Lead Sponsor
Aviva Abosch
University of Colorado, Denver
Chief Medical Officer since 2019
MD
Uday B. Kompella
University of Colorado, Denver
Chief Executive Officer since 2015
PhD in Pharmaceutical Sciences